Publications by authors named "Daniel D Shapiro"

Claim this Profile
O
Outcomes of Patients with Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation.
Parth V Shah, E Jason Abel, Joshua D Mezrich, Andrew Z Carey, Amy K Taylor, Daniel D Shapiro

Urology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy.
Ali Ghasemzadeh, E Jason Abel, Jose A Karam, Philippe E Spiess, Charles C Peyton, Daniel D Shapiro

J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, Dena Battle, Stephanie A Berg

Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinoma.
Daniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, Ayman Isahaku, Schyler M Turner

Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psammomatous Calcifications Identified in Targeted Needle Biopsies and Radical Prostatectomy From IDH1 Mutant Prostatic Adenocarcinoma : Case Report and Literature Review.
Yang Zong, Mark Sharobim, Edward M Lawrence, Rong Hu, Wei Huang, Daniel D Shapiro

Am J Surg Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy.
Estelle Ndukwe, Paz Lotan, Michael Risk, Elizabeth L Koehne, Daniel D Shapiro

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
Axel Bex, Michael Jewett, Bryan Lewis, E Jason Abel, Laurence Albiges, Daniel D Shapiro

Eur Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy for renal cell carcinoma: Finding the signal in the noise.
Daniel D Shapiro, Pavlos Msaouel

Urol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power.
Daniel D Shapiro, Pavlos Msaouel

Eur Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting.
Stephanie A Berg, Salvatore La Rosa, Tian Zhang, Phillip M Pierorazio, Laurence Albiges, Daniel D Shapiro

Urol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach.
Rahim Jiwani, Koustav Pal, Iwan Paolucci, Bruno Odisio, Kristy Brock, Daniel D Shapiro

Oncologist· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial.
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma.
Edouard H Nicaise, Benjamin N Schmeusser, Gregory Palmateer, Khushali Vashi, Krishna Parikh, Daniel D Shapiro

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma.
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam

Res Sq· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.
Gregory Palmateer, Edouard H Nicaise, Taylor Goodstein, Benjamin N Schmeusser, Dattatraya Patil, Daniel D Shapiro

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.
E Jason Abel, Viraj A Master, Philippe E Spiess, Jay D Raman, Daniel D Shapiro

Eur Urol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274.
E Jason Abel, Viraj A Master, Philippe E Spiess, Jay D Raman, Daniel D Shapiro

Eur Urol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion.
Arighno Das, Erica Zeng, Michael Risk, Daniel D Shapiro, Edwin Jason Abel

Urology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery.
Daniel D Shapiro, Taja Lozar, Lingxin Cheng, Elliot Xie, Israa Laklouk

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.
Daniel D Shapiro, Jose A Karam, Viraj A Master, Wade J Sexton, Surena F Matin

Eur Urol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients.
Ashanda R Esdaille, Jose A Karam, Viraj A Master, Philippe E Spiess, Jay D Raman, Daniel D Shapiro

Urology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Agent Orange Exposure on Non-muscle Invasive Bladder Cancer Outcomes.
Taylor Penn, Tudor Borza, Jinn-Ing Liou, E Jason Abel, Daniel D Shapiro

Urology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of stage 1 renal cell cancer in patients immunosuppressed for organ transplantation or autoimmune disease.
Ali Ghasemzadeh, Eric T Wendt, Brendan Dolan, Juliana Craig, Glenn O Allen, Daniel D Shapiro

Front Urol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC.
Arighno Das, Daniel D Shapiro, Juliana K Craig, E Jason Abel

Nat Rev Urol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
Daniel D Shapiro, Niki Millward Zacharias, Durga N Tripathi, Menuka Karki, Jean-Philippe Bertocchio

Clin Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis